Stephanie Lehoux
slehoux@mailcity.com
We did not in fact test herbimycin A against baseline MAP kinase activity at control pressures. However, since this drug blocked steady stretch-induced MAP kinase activation but not pulsatile stretch- induced activation, I suspect that the effects we see with herbimycin A are rather specific for steady stretch. Furthermore, they coincide with conditions where FAK is also activated (compared to vessels at control pressure), which points to a possible transduction pathway of steady stretch involving interaction of Src-family tyrosine kinases with FAK and subsequent downstream activation of MAP kinase.